Functional Cure Study of Anti-PD-L1 Antibody ASC22 in Combination With Chidamide in HIV-infected Patients With Antiviral Suppression
Clinical trial NCT05129189 · UNKNOWN
Trial details
- NCT number
- NCT05129189
- Sponsor
- Shanghai Public Health Clinical Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-29
- Primary completion
- 2023-07-30
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.